Stelzner Sigmar, Lange Undine Gabriele, Rabe Sebastian Murad, Niebisch Stefan, Mehdorn Matthias
Klinik für Viszeral‑, Transplantations‑, Thorax- und Gefäßchirurgie, Universitätsklinikum Leipzig, AöR, Liebigstraße 20, 04103, Leipzig, Deutschland.
Chirurgie (Heidelb). 2025 Apr;96(4):293-305. doi: 10.1007/s00104-024-02212-9. Epub 2025 Jan 10.
Lymphadenectomy for rectal cancer is clearly defined by total mesorectal excision (TME). The analogous surgical strategy for the colon, the complete mesocolic excision (CME), follows the same principles of dissection in embryologically predefined planes.
This narrative review initially identified key issues related to lymphadenectomy of rectal and colon cancer. The subsequent search was based on PubMed and focused on meta-analyses. The endpoints for rectal cancer were the benefit of high tie versus low tie and the indications for lateral pelvic lymphadenectomy. For colon cancer the evidence for CME, for the longitudinal extent of resection, for the dissection of infrapyloric and gastroepiploic lymph nodes, for the number of lymph nodes and for the sentinel lymph node technique were used as endpoints.
An oncological benefit of the high tie cannot be derived from the current data. Lateral pelvic lymphadenectomy should only be selectively performed after chemoradiotherapy (CRT) in cases of remaining lymph nodes with suspected metastases. In most studies CME proved to be oncologically superior, especially in stage III. The longitudinal extent of resection should be at least 10 cm in both directions if the principles of CME are observed. Infrapyloric and gastroepiploic lymph node involvement is to be expected in 0.7-22% of cases, depending on patient selection, which justifies dissection, particularly in carcinomas of both flexure and the transverse colon. The minimum number of lymph nodes to be removed cannot be clearly derived from the available studies. Precisely performed CME and an optimal pathological work-up are important. The sentinel lymph node technique cannot currently be used as a criterion for limiting the extent of resection.
Both TME and CME are reliable standards for the lymphadenectomy in colorectal carcinomas. A lymphadenectomy that goes beyond this is reserved for selected cases and is partly the subject of currently ongoing studies.
直肠癌的淋巴结清扫术通过全直肠系膜切除术(TME)有明确的定义。结肠癌类似的手术策略,即完整结肠系膜切除术(CME),遵循在胚胎学预先定义平面进行相同的解剖原则。
本叙述性综述首先确定了与直肠癌和结肠癌淋巴结清扫术相关的关键问题。随后的检索基于PubMed并聚焦于荟萃分析。直肠癌的终点指标是高位结扎与低位结扎的益处以及侧方盆腔淋巴结清扫术的指征。对于结肠癌,CME的证据、切除的纵向范围、幽门下和胃网膜淋巴结的清扫、淋巴结数量以及前哨淋巴结技术被用作终点指标。
目前的数据无法得出高位结扎的肿瘤学益处。侧方盆腔淋巴结清扫术仅应在怀疑有转移的残留淋巴结病例中,在放化疗(CRT)后选择性进行。在大多数研究中,CME被证明在肿瘤学上更具优势,尤其是在III期。如果遵循CME原则,切除的纵向范围在两个方向上都应至少为10厘米。根据患者选择,0.7%-22%的病例预计会有幽门下和胃网膜淋巴结受累,这证明了清扫的合理性,特别是在结肠肝曲和横结肠癌中。现有研究无法明确得出应切除的淋巴结的最小数量。精确实施CME和最佳的病理检查很重要。目前,前哨淋巴结技术不能用作限制切除范围的标准。
TME和CME都是结直肠癌淋巴结清扫术的可靠标准。超出此范围的淋巴结清扫术仅适用于特定病例,并且部分是当前正在进行的研究的主题。